INDP

$1.96

Post-MarketAs of Mar 17, 8:00 PM UTC

Indaptus Therapeutics, Inc., a clinical biotechnology company, develops various anti-cancer and anti-viral immunotherapy products.

OverviewIntradayAnalysisPROIntelligencePROAsk AIPRO

Intraday

Custom Range:
to
No data available for this range. Intraday data may be limited by the exchange.

Recent News

MT Newswires
Sep 5, 2025

Wall Street Set to Open Higher Friday; Nonfarm Payrolls Fall Well Short of Forecasts

US stocks look set to open higher in Friday's trading session as investors parse key jobs data showi

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.